New platform addresses rising consumer expectations and affordability challenges, using GLP-1 therapies as a proof point PHIL, a leader in patient access solutions for the
Canarys is proud to announce the launch of Auryis, their AI-powered, unified compliance assessment platform purpose-built for Pharma and Life Sciences. This marks a pivotal
Strategic partnership to accelerate U.S. growth, product innovation, and long-term value creation in life sciences supply chain. Ampersand Capital Partners, a private equity firm specializing
New offering personalizes omnichannel campaigns for every HCP using predictive insights on prescribing behavior, not traditional personas ODAIA announced its entry into the omnichannel marketing
Konstellate, a leading provider of AI technology to power Key Opinion Leaders (KOLs) intelligence for pharma decision-makers, announced the launch of its new platform. It
